RX-10001 (RvE1) an Endogenously Formed Immune Modulator Attenuates Clinical Signs of Autoimmune Disease in the Rat CIA Model Concurrent With Inhibition of T-Cell Dependent Cytokines in Mixed Cell Populations From Draining Lymph Nodes